U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Leflunomide (marketed as Arava) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Leflunomide (marketed as Arava) Information

Arava (leflunomide) is indicated in adults for the treatment of active rheumatoid arthritis (RA):

 

  1. to reduce signs and symptoms
  2. to inhibit structural damage as evidenced by X-ray erosions and joint space narrowing
  3. to improve physical function.

 

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

Labeling and Regulatory History from Drugs@FDA